Physician
Marquez-Smith, Teresa
Marquez-Smith, Teresa was paid $3.35M by Medicaid between Jan 2018 and Dec 2024, across 69 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 45% of everything it billed.
33Billing provider infoMARQUEZ-SMITH, TERESA
EL PASO, TX 79936
EL PASO, TX 79936
33aNPI1114998051assigned 01/30/2006
33bProvider typePediatrics Physician
28Total paid$3.35M
24GClaims107,838
24DCodes billed69
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#140 of 1,136
Median peer was paid$329K
This provider vs. median10×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 364 | $21K | |
| 2019 | 110 | $7K | |
| 2020 | 4,271 | $130K | |
| 2021 | 26,898 | $796K | |
| 2022 | 31,421 | $935K | |
| 2023 | 25,568 | $802K | |
| 2024incomplete | 19,206 | $659K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 45% | 28,428 | 22,350 | $1.52M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.4% | 6,545 | 5,993 | $247K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.8% | 2,548 | 2,530 | $226K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.3% | 2,493 | 2,461 | $210K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.6% | 2,100 | 2,083 | $189K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.6% | 14,126 | 7,789 | $154K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 4.4% | 4,238 | 4,012 | $148K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.3% | 1,446 | 1,334 | $110K |
| 94060 | 3.0% | 2,610 | 2,602 | $102K | |
| 99429 | 2.0% | 2,125 | 2,112 | $69K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.0% | 4,872 | 4,687 | $67K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.9% | 808 | 801 | $65K |
57 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.3% | 2,699 | $44K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 3,327 | $31K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 872 | $23K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,190 | $17K |
| 0072A | <1% | 373 | $14K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 195 | $14K |
| 90461 | <1% | 2,691 | $11K | |
| 92587 | <1% | 812 | $11K | |
| 0003A | <1% | 389 | $10K | |
| 0071A | <1% | 257 | $10K | |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | <1% | 383 | $8K |
| 0124A | <1% | 181 | $7K | |
| 0154A | <1% | 169 | $6K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 70 | $6K |
| 0081A | <1% | 161 | $6K | |
| 0074A | <1% | 135 | $5K | |
| 0082A | <1% | 129 | $5K | |
| 87807 | <1% | 446 | $5K | |
| 96160 | <1% | 1,752 | $3K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 47 | $3K |
| 90480 | <1% | 54 | $1K | |
| 81002 | <1% | 391 | $1K | |
| 85018 | <1% | 1,037 | $989.06 | |
| 0002A | <1% | 32 | $956.00 | |
| 0083A | <1% | 24 | $880.00 | |
| 96112 | <1% | 54 | $780.00 | |
| 0001A | <1% | 20 | $758.00 | |
| 82947 | <1% | 103 | $342.73 | |
| 90686 | <1% | 3,677 | $59.71 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 82 | $53.18 |
| 94760 | <1% | 852 | $48.76 | |
| J1094 | Injection, dexamethasone acetate, 1 mg | <1% | 2,279 | $7.91 |
| 91307 | <1% | 1,033 | $0.20 | |
| 90620 | <1% | 607 | $0.20 | |
| 91300 | <1% | 609 | $0.15 | |
| 91320 | <1% | 104 | $0.12 | |
| 90651 | <1% | 570 | $0.05 | |
| 90715 | <1% | 167 | $0.05 | |
| 91319 | <1% | 128 | $0.04 | |
| 90685 | <1% | 498 | $0.04 | |
| 91312 | <1% | 185 | $0.04 | |
| 90677 | <1% | 199 | $0.03 | |
| 90734 | <1% | 538 | $0.02 | |
| 91308 | <1% | 364 | $0.02 | |
| 90723 | <1% | 793 | $0.01 | |
| 90696 | <1% | 56 | $0.01 | |
| 91315 | <1% | 159 | $0.01 | |
| 90648 | <1% | 1,234 | $0.01 | |
| 90670 | <1% | 960 | $0.01 | |
| 90710 | <1% | 46 | $0.01 | |
| 90716 | 0% | 90 | $0.00 | |
| 90381 | 0% | 135 | $0.00 | |
| 91318 | 0% | 70 | $0.00 | |
| 90707 | 0% | 106 | $0.00 | |
| 90633 | 0% | 606 | $0.00 | |
| 90681 | 0% | 275 | $0.00 | |
| 90700 | 0% | 84 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.